Use of Cangrelor for Patients Undergoing Coronary Artery Bypass Grafting

JENNIFER A. RYMER; Courtney Page; Brooke Alhanti; Cayla Pichan; Aman Kansal; Deepak L Bhatt; Ajar Kochar; Dominick J. Angiolillo; Miguel Diaz; Neil J Wimmer; Lawrence Ang; Richard Bach; Ronald Jenkins; Leo Brothers; W. Schuyler Jones; Jeffrey B. Washam; Tracy Y Wang; Dennis I. Narcisse; Mir B. Basir; Abhishek Chaturvedi; Ron Waksman; JENNIFER A. RYMER; Courtney Page; Brooke Alhanti; Cayla Pichan; Aman Kansal; Deepak L Bhatt; Ajar Kochar; Dominick J. Angiolillo; Miguel Diaz; Neil J Wimmer; Lawrence Ang; Richard Bach; Ronald Jenkins; Leo Brothers; W. Schuyler Jones; Jeffrey B. Washam; Tracy Y Wang; Dennis I. Narcisse; Mir B. Basir; Abhishek Chaturvedi; Ron Waksman

doi:10.1016/j.jacadv.2025.102280

Key Points

To evaluate the impact of Cangrelor on timing and outcomes in patients undergoing CABG after AMI.
Examined cangrelor use in patients with acute myocardial infarction (AMI) undergoing coronary artery bypass grafting (CABG)
Compared hospital admission times and length of stay for cangrelor-treated versus non-treated patients
Over 25% of cangrelor-treated patients received 'bridge' dosing prior to CABG
Cangrelor treatment was associated with significantly shorter hospital admission to CABG times
Patients treated with cangrelor had a reduced overall length of stay.

Implication

Cangrelor treatment reduces hospital admission and length of stay in AMI patients undergoing CABG, suggesting clinical benefits.

Abstract

Cangrelor use in patients with AMI undergoing CABG varies, with over 25% of cangrelor-treated patients receiving "bridge" dosing prior to CABG. Timing from hospital admission to CABG and overall length of stay were significantly shorter in cangrelor-treated patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

RYMER et al. (2025) studied this question.

synapsesocial.com/papers/6924f091c0ce034ddc3508a0 https://doi.org/10.1016/j.jacadv.2025.102280

View Full Paper

Ask AI

Bookmark

Share

Use of Cangrelor for Patients Undergoing Coronary Artery Bypass Grafting

Key Points

Implication

Abstract

Discussion

Cite This Study

Use of Cangrelor for Patients Undergoing Coronary Artery Bypass Grafting

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading